High Vista Strategies LLC Galapagos Nv Transaction History

High Vista Strategies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$31.87 - $40.71 $22,117 - $28,252	-694 Reduced 5.09%	12,953 $526,000
Q3 2023 Nov 14, 2023	BUY	$34.17 - $42.98 $466,317 - $586,548	13,647 New	13,647 $471,000
Q4 2022 Feb 14, 2023	BUY	$37.44 - $46.51 $119,882 - $148,925	3,202 Added 18.3%	20,701 $918,000
Q3 2022 Nov 14, 2022	BUY	$42.27 - $57.6 $240,854 - $328,204	5,698 Added 48.28%	17,499 $746,000
Q2 2022 Aug 15, 2022	SELL	$52.3 - $71.59 $73,638 - $100,798	-1,408 Reduced 10.66%	11,801 $658,000
Q1 2022 May 16, 2022	BUY	$51.32 - $68.5 $677,885 - $904,816	13,209 New	13,209 $819,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.